Rochelle Stenzler

Rochelle Stenzler has more than 25 years of experience as a board director and senior operating executive in healthcare and other industries. A pharmacist by education and training, Ms. Stenzler has served as Board Chair of Spartan Bioscience since August 2020. Prior to this role, she served as Board Chair of Cynapsus Therapeutics, until it was acquired for C $841M by Sunovion Pharmaceuticals in 2016. She has previously served as a Board Director & Vice Chair of Humber River Hospital; President & CEO of TouchLogic Corporation; President, International Operations of TLC Laser Eye Centers; President, Revlon Canada; and President and General Manager of Pharma Plus Drugmarts Ltd.

Ms. Stenzler also has extensive corporate governance experience, which includes serving as a member of the Spartan Bioscience Finance, Audit and Risk Committee; Vice-Chair and Chair of the Nominating, Governance, and Human Resources Committee of the Humber River Hospital in Toronto; and as an Advisory Board member to Social Capital Partners. Ms. Stenzler is a graduate of the University of Toronto with a BSc.Phm. and a Gold Medal in Compounding and Dispensing, and the Rotman School of Management, Institute of Corporate Directors, with an ICD.D.